Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (6) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (2) Janz, Martin Dr. (8) Kammertöns, Thomas Dr. (2) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (1) Mathas, Stephan Dr. (8) Rajewsky, Nikolaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (9) Willimsky, Gerald Dr. (1) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Lusatis, Simone (1) (-) Pezzutto, Antonio Prof. Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (3) (-) Biologie maligner Lymphome (1) Experimentelle Ultrahochfeld-MR (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Hochschulambulanz für Neuroimmunologie (1) Magnetic Resonance (1) (-) Molekulare Immunologie und Gentherapie (4) Zelluläre Neurowissenschaften (1) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2003 (4) 2004 (2) (-) 2006 (2) 2007 (3) 2008 (1) 2010 (2) (-) 2011 (3) 2013 (1) 2014 (2) 2015 (3) 2016 (2) 2017 (1) 2018 (3) 2019 (1) 2020 (1) 2021 (1) 2022 (2) 2023 (1) 5 Ergebnisse: Active Filter: Leisegang, Matthias Prof. Dr. rer. nat.Lusatis, SimonePezzutto, Antonio Prof. Dr.Uckert, Wolfgang Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 20062011 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein